Objectives: Lifestyle factors such as nutrition and physical activity play an important role in the management of diabetes mellitus. Unfortunately, adherence to lifestyle change remains low among patients with diabetes. The aim of this study was to evaluate the effectiveness of the Diabetes Score questionnaire in a clinical setting. Methods: The Diabetes Score is a 10-item shared decision-making tool designed to empower lifestyle change in individuals with diabetes. It yields an intuitive score from 0 to 100 based on a patient’s adherence to lifestyle recommendations. An observational study was conducted at an ambulatory health care center. After obtaining written informed consent, adult patients with type 2 diabetes mellitus were interviewed by a trained researcher using the Diabetes Score questionnaire. Patients’ Diabetes Score values were analyzed in reference to their glycemic control and other clinical and demographic factors. Results: A total of 60 individuals with type 2 diabetes participated in the study. The mean age was 56 years (minimum 43 years, maximum 70 years) with 60% being males. Higher Diabetes Scores correlated with better glycemic control (hemoglobin A1C; r = −0.23, p = 0.044) indicating the effect of lifestyle factors such as healthy nutrition, smaller portion sizes, active lifestyle, and aerobic exercise. The questionnaire showed internal consistency (alpha 0.66), construct validity, and high patient satisfaction (98%). Conclusion: Diabetes Score, a behavioral lifestyle questionnaire, correlates with glycemic control in type 2 diabetes. Diabetes Score can be used in clinical settings for measuring, discussing, and setting targets for lifestyle change among patients with diabetes.

Type 2 diabetes mellitus is primarily a lifestyle condition. Diabetes is influenced by lifestyle and in turn affects the quality of life. Modifiable lifestyle risk factors are important in diabetes care as they are independently associated with diabetes [1]. Thus, a holistic approach to diabetes care is needed in which patients are empowered to make lifestyle changes. By itself, pharmacologic management does not ensure improvement in long-term patient-oriented outcomes such as the quality of life or all-cause mortality. Additional nonpharmacologic interventions are needed to empower individuals to improve their quality of life [2]. Yet, a majority of these individuals remain nonadherent to lifestyle guidelines [3].

The Diabetes Score questionnaire is a behavior change tool designed to improve lifestyle factors such as diet and exercise in individuals with diabetes (online suppl. Material; for online suppl. material, see www.karger.com/doi/10.1159/000519225). This instrument consists of 10 questions pertaining to physical activity, nutrition, and self-care. Each question is rated by patients on a scale from 0 to 10 points based on the level of adherence. A total score (ranging from 0 to 100) is obtained by adding the points from the 10 individual questions. The questionnaire has been carefully designed for clinical use. All items are actionable and behaviorally oriented. Thus, items that cannot be changed directly by patients themselves, such as blood glucose levels or BMI, are excluded. This is in contrast to the traditional biomedical approach to self-management, which has failed to yield meaningful results [4]. Previous research has shown that knowledge of glycemic control and recommended targets does not translate into lifestyle change [4‒6]. One study concluded that “Strategies to provide information to patients must be combined with other behavioral strategies to motivate and help patients effectively manage their diabetes” [6].

All regions of the world are experiencing an epidemic of obesity and type 2 diabetes [7]. Diabetes tends to be underdiagnosed and undertreated [8]. Patients’ knowledge about diabetes and self-management remains low [9]. Glycemic levels are suboptimally controlled despite advances in diabetes therapy [10]. There is an urgent need for a practical, low-cost patient decision aid for diabetes self-management. We aimed to evaluate the Diabetes Score questionnaire in a clinical context. In particular, we sought to assess whether Diabetes Score correlates with better glycemic control among adult patients with diabetes.

Study Design

A cross-sectional questionnaire survey was conducted at a primary care clinic in the city of Al Ain, United Arab Emirates, in 2018. Researcher-administered structured brief interviews were conducted with otherwise healthy, community-dwelling, adult individuals with type 2 diabetes in an ambulatory setting.

Study Sample

Inclusion criteria for recruitment of subjects in the study were age 18 years or greater and an established diagnosis of type 2 diabetes mellitus. Exclusion criteria included any mental or hearing deficits and other severe medical conditions such as mobility restrictions that would impede participation in the study. A minimum sample size of 47 subjects was deemed sufficient to detect a correlation of 0.4 between Diabetes Score and hemoglobin A1C (power 80%, 2-tailed alpha 0.05).

Data Collection

A trained researcher (H.M.) conducted all the interviews to ensure consistency and reliability. Patients in the clinic waiting area were offered information about the study, and voluntary informed consent was requested. Preprinted questionnaire forms were used to collect data in a structured format. The primary outcome measure was the level of correlation between glycemic control (HbA1c) and the patient’s Diabetes Score. Demographic (age, gender, occupation, and education) and clinical (weight, recent blood glucose, and HbA1C) data were recorded. Additionally, patients’ satisfaction with Diabetes Score was assessed by asking their perceptions and whether they would use the questionnaire in the future.

Statistical Analysis

Statistical data analysis was conducted using the current version of SPSS Statistics (version 26; IBM SPSS Inc., Armonk, NY, USA). In addition to descriptive measures, statistical tests for bivariate correlation, t test, and multivariate regression were performed. Reliability analysis was assessed using the alpha (Cronbach) model. Factor analysis was used to evaluate principal components (subscales) for diet, exercise, and self-care. An alpha level of 0.05 was considered statistically significant.

A total of 60 adult patients with type 2 diabetes mellitus participated in the study. The sample was representative of a wide range of diabetic patients (Table 1). The ages ranged from 43 to 70 years (mean 56; standard deviation [SD], 5.7). Males constituted 60% of the sample. A broad range of occupations (electricians and engineers to farmers and carpenters) and educational backgrounds (mean years of formal education, 13; SD, 2.6) was present. Most (70%) patients were diagnosed within 10 years and about one-fourth were suboptimally controlled with a hemoglobin A1C >7% (53 mmol/mol).

The mean Diabetes Score was 55.1 points (SD, 17.8) in this sample. Patients were more adherent to dietary items than to exercise or physical activity (Fig. 1). The correlation with hemoglobin A1C was −0.23 (p = 0.044), indicating that higher Diabetes Scores were associated with better glycemic control. Diabetes Score correlated with BMI (r = −0.37, p = 0.003) and education (r = 0.22, p = 0.049) but not with age or duration of diabetes. There was no significant difference between male and female patients in terms of glycemic control (A1C 6.8% vs. 6.9%; p = 0.74) or the Diabetes Score (mean Score 57 vs. 53; p = 0.45).

Fig. 1.

Self-rated scores for the 10 items of the Diabetes Score questionnaire in patients with diabetes (n = 60).

Fig. 1.

Self-rated scores for the 10 items of the Diabetes Score questionnaire in patients with diabetes (n = 60).

Close modal

Participants were divided into 2 groups: those with a Diabetes Score >55 points (indicating better adherence to lifestyle recommendations) and those with ≤55 points (suboptimal adherence). Comparison of these 2 groups showed that better Diabetes Scores were associated with significantly lower BMI and improved glycemic control (Table 2). On multivariate analysis using multiple linear regression with HbA1C as the outcome variable, none of the variables including Diabetes Score, age, duration of diabetes, education, or BMI were statistically significant predictors of glycemic control (adjusted R2 = 0.051). A refined model showed that age and Diabetes Score were weak predictors (adjusted R2 = 0.104; for Diabetes Score: F = 2.9, p = 0.093).

The questionnaire data were analyzed for reliability and acceptability. Reliability analysis for internal consistency yielded a Cronbach alpha of 0.66 for the 10 items. Factor analysis (using varimax rotation) revealed well-separated subscales for diet and exercise with eigenvalues explaining 19% and 20% of variance, respectively. Patient satisfaction with Diabetes Score was also assessed: 98% of participants indicated that the questionnaire was okay, good, or better, while 38% would use it in the future.

Diabetes Score was associated with better glycemic control among adult patients with type 2 diabetes. The questionnaire showed fair evidence of construct validity, internal consistency, reliability, and patient satisfaction. Previous studies have used a similar cross-sectional study design to assess diabetes questionnaires [11‒13].

We found that patients were more likely to comply with dietary guidelines than with exercise. This is consistent with previous research showing the impact of diabetes on the ability to exercise [14]. Foot care was often neglected, indicating an area for self-improvement. The rate of obesity (40%) in our study sample was lower than the rate observed in patients with diabetes elsewhere [15]. Self-reported adherence to diabetes medications was high in our survey indicating awareness of its importance. However, the goal of diabetes education is not merely to increase patients’ knowledge but rather to empower patients to make lifestyle changes. Knowledge of diabetes self-management has tended to remain low despite counseling by dieticians and diabetes educators [9]. In resource-limited settings such as developing countries, where the largest numbers of diabetes patients reside, frequent blood tests and physician visits may not be feasible. Innovative approaches are needed to focus on low-cost, nonpharmacological interventions such as lifestyle change [16].

Previous diabetes questionnaires have tended to be lengthy and complicated, making them unsuitable for use in clinical settings [11, 13]. Many questionnaires were designed for gathering data for research purposes, rather than for improving patient care. Thus, a questionnaire is needed that can be used not only for measuring adherence to diet and exercise but also for discussing targets and monitoring progress. Unfortunately, many questionnaires include items that are not directly modifiable or actionable. Some items are not evidence based such as frequent checking blood glucose in type 2 diabetes controlled with oral medications. The Diabetes Score questionnaire fills this critical gap. It is a brief, behavioral checklist designed specifically to empower patients to take control of their lifestyle. The 10 items in the questionnaire are simple and actionable. The questionnaire is easy to score, and its results are intuitively understandable (unlike other questionnaires with complicated scoring). Despite widespread efforts at diabetes education in clinics and the community, most patients do not receive adequate instruction [3]. Diabetes Score is designed to be used as an educational tool during counseling by a healthcare professional. Physicians and nurses can engage patients, set targets, and measure progress using Diabetes Score. It can thus form a component of a comprehensive chronic disease care process (Fig. 2). By focusing on patient empowerment, Diabetes Score can be a part of a holistic framework for diabetes care [16].

Fig. 2.

Diabetes treatment algorithm using Diabetes Score. SU, sulfonylureas; TZD, thiazolidinedione (“-glitazones”); GLP1, glucagon-like peptide 1 receptor agonist (“-tides”); SGLT2, sodium-glucose cotransporter 2 inhibitor (“-iflozin”); DPP4, dipeptidyl peptidase 4 inhibitor (“-liptin”).

Fig. 2.

Diabetes treatment algorithm using Diabetes Score. SU, sulfonylureas; TZD, thiazolidinedione (“-glitazones”); GLP1, glucagon-like peptide 1 receptor agonist (“-tides”); SGLT2, sodium-glucose cotransporter 2 inhibitor (“-iflozin”); DPP4, dipeptidyl peptidase 4 inhibitor (“-liptin”).

Close modal

The study was limited by the context of a single clinic located in an urban setting. Language may be an issue as some patients had limited literacy. However, a bilingual researcher experienced in this setting conducted the interviews. On multivariate modeling, Diabetes Score did not reach statistical significance (p = 0.09) as a predictor of glycemic control. Further studies using a prospective study design are needed to confirm these findings.

The Diabetes Score is a brief, behavioral questionnaire for lifestyle self-management in diabetes. Results from this study indicate that higher Diabetes Score correlates with better glycemic control. The questionnaire has favorable internal consistency and reliability. It appears to be useful for discussing and promoting healthy nutrition, increasing physical activity, and engaging in self-care among adult patients with type 2 diabetes.

We would like to thank the participants of the study.

The study was approved by the Al Ain Medical District Human Research Ethics Committee (Ref: DT/bb/15-21; 10-05-2015). Written informed consent was obtained from the participants, and no personally identifiable information such as names or addresses was recorded. Financial incentives were not provided to the subjects for participation in the study. The study was carried out in accordance with the Helsinki Declaration Principles. The safety, privacy, and voluntary participation of subjects were respected at all times.

The authors have no potential conflicts of interest to disclose.

The study was supported by an internal university research grant (College of Medicine and Health Sciences Faculty Grant).

M.J.H. contributed to design, conception, manuscript drafting, critical analysis, and final approval. H.M. contributed to data collection, manuscript drafting, critical analysis, and final approval.

Data that support the findings of this study are available from the corresponding author upon reasonable request.

1.
Mirghani
HO
,
Saleh
A
.
Diabetes risk among medical students in Tabuk city, Saudi Arabia
.
Dubai Diabetes Endocrinol J
.
2020
;
26
(
1
):
27
30
.
2.
Onyenekwe
BM
,
Young
EE
,
Nwatu
CB
,
Okafor
CI
,
Ugwueze
CV
.
Diabetes distress and associated factors in patients with diabetes mellitus in South East Nigeria
.
Dubai Diabetes Endocrinol J
.
2020
;
26
(
1
):
31
7
.
3.
Aladhab
RA
,
Alabbood
MH
.
Adherence of patients with diabetes to a lifestyle advice and management plan in Basra, Southern Iraq
.
Int J Diabetes Metab
.
2019
;
25
(
3–4
):
100
5
.
4.
Stark Casagrande
S
,
Ríos Burrows
N
,
Geiss
LS
,
Bainbridge
KE
,
Fradkin
JE
,
Cowie
CC
.
Diabetes knowledge and its relationship with achieving treatment recommendations in a national sample of people with type 2 diabetes
.
Diabetes Care
.
2012 Jul
;
35
(
7
):
1556
65
.
5.
Colleran
KM
,
Starr
B
,
Burge
MR
.
Putting diabetes to the test: analyzing glycemic control based on patients’ diabetes knowledge
.
Diabetes Care
.
2003 Jul
;
26
(
7
):
2220
1
.
6.
Heisler
M
,
Piette
JD
,
Spencer
M
,
Kieffer
E
,
Vijan
S
.
The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management
.
Diabetes Care
.
2005 Apr
;
28
(
4
):
816
22
.
7.
Khan
MAB
,
Hashim
MJ
,
King
JK
,
Govender
RD
,
Mustafa
H
,
Al Kaabi
J
.
Epidemiology of type 2 diabetes – global burden of disease and forecasted trends
.
J Epidemiol Glob Health
.
2020
;
10
(
1
):
107
11
.
8.
Sulaiman
N
,
Albadawi
S
,
Abusnana
S
,
Mairghani
M
,
Hussein
A
,
Al Awadi
F
,
.
High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional survey
.
Sci Rep
.
2018 May
;
8
(
1
):
6862
.
9.
Hashim
MJ
,
Mustafa
H
,
Ali
H
.
Knowledge of diabetes among patients in the United Arab Emirates and trends since 2001: a study using the Michigan diabetes knowledge test
.
East Mediterr Health J
.
2017 Jan
;
22
(
10
):
742
8
.
10.
Alawadi
F
,
Abdelgadir
E
,
Bashier
A
,
Hassanein
M
,
Rashid
F
,
Alsaeed
M
,
.
Glycemic control in patients with diabetes across primary and tertiary government health sectors in the Emirate of Dubai, United Arab Emirates: a five-year pattern
.
Oman Med J
.
2019 Jan
;
34
(
1
):
20
5
.
11.
Schmitt
A
,
Gahr
A
,
Hermanns
N
,
Kulzer
B
,
Huber
J
,
Haak
T
.
The diabetes self-management questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control
.
Health Qual Life Outcomes
.
2013
;
11
:
138
.
12.
Bradley
C
,
Todd
C
,
Gorton
T
,
Symonds
E
,
Martin
A
,
Plowright
R
.
The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL
.
Qual Life Res
.
1999 Jan
;
8
(
1–2
):
79
91
.
13.
Khader
YS
,
Bataineh
S
,
Batayha
W
.
The Arabic version of diabetes-39: psychometric properties and validation
.
Chronic Illn
.
2008 Dec
;
4
(
4
):
257
63
.
14.
Midhet
FM
,
Al-Mohaimeed
AA
,
Sharaf
FK
.
Lifestyle related risk factors of type 2 diabetes mellitus in Saudi Arabia
.
Saudi Med J
.
2010 Jul
;
31
(
7
):
768
74
.
15.
Meo
SA
,
Sheikh
SA
,
Sattar
K
,
Akram
A
,
Hassan
A
,
Meo
AS
,
.
Prevalence of type 2 diabetes mellitus among men in the Middle East: A Retrospective Study
.
Am J Mens Health
.
2019 Jun
;
13
(
3
):
1557988319848577
.
16.
Alawadi
F
,
Abusnana
S
,
Afandi
B
,
Aldahmani
KM
,
Alhajeri
O
,
Aljaberi
K
,
.
Emirates Diabetes Society consensus guidelines for the management of type 2 diabetes mellitus – 2020
.
Dubai Diabetes Endocrinol J
.
2020
;
26
(
1
):
1
20
.